Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

BACKGROUND: The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) is an efficient treatment of non-Hodgkin’s lymphoma (NHL). This study aimed to assess the efficacy and toxicity of dose-adjusted CHOP alone or in combination with rituximab (R-CHOP) by examining the stem c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chin J Cancer
Main Authors: Shi, Yuankai, Zhou, Ping, Han, Xiaohong, He, Xiaohui, Zhou, Shengyu, Liu, Peng, Yang, Jianliang, Zhang, Changgong, Gui, Lin, Qin, Yan, Yang, Sheng, Zhao, Liya, Yao, Jiarui, Zhang, Shuxiang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593367/
https://ncbi.nlm.nih.gov/pubmed/26370464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0045-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados